Skip to main content

Table 3 Univariate and multivariate analyses to predict RFS

From: Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor

Variable

Univariate Analysis

 

Multivariate Analysis

 
 

HR (95% CI)

P value

HR (95% CI)

P value

Age (>60y)

1.025 (0.732, 1.434)

0.887

  

Gender (male)

0.993 (0.709, 1.391)

0.969

  

Location (non-stomach)

1.926 (1.373, 2.701)

< 0.001

0.965 (0.679, 1.372)

0.884

Tumor size (≥5 cm)

6.666 (4.399, 10.101)

< 0.001

3.228 (2.057, 5.067)

< 0.001

Mitotic rate (> 5)

8.317 (5.805, 11.406)

< 0.001

4.071 (2.825, 5.886)

< 0.001

NLR (≥2.34)

2.737 (1.903, 3.937)

< 0.001

1.302 (0.881, 1.925)

0.186

PLR (≥185.04)

6.331 (4.364, 9.184)

< 0.001

3.041 (2.001, 4.622)

< 0.001

  1. RFS recurrence-free survival, HR hazard ratio, CI confidence interval,
  2. NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio
  3. Bold values indicate statistical significance at P < 0.05